Knowledge of HPV-Related Oropharyngeal Cancer and Use of Human Papillomavirus Vaccines by Pediatricians in Louisiana

Vikas Mehta, MD, MPH, FACS; Sean Holmes, MD; Adam Master, MD; Blake Leblanc, MD; L. Gloria Caldito, PhD; Joseph Bocchini, Jr., MD; Cherie-Ann Nathan, MD, FACS

 

OBJECTIVES

To determine the level of knowledge of HPV related oropharyngeal cancer and practice patterns of HPV vaccine use by pediatricians.

STUDY DESIGN, SUBJECTS, METHODS

IRB approved 18-question survey was administered to members of the Louisiana Chapter of the American Academy of Pediatrics. 

RESULTS

We received 116 responses (response rate: 15.9%). 104 respondents (89.66%) routinely recommend/offer HPV vaccine, 6 (5.17%) occasionally or only at caregiver request, and 6 (5.17%) do not offer the vaccine. 17 (15.5%) reported having no awareness of the link between oropharyngeal cancer and HPV, and only 50 (45.9%) had knowledge that HPV-related oropharyngeal cancer incidence was increasing. Strength of recommendation for males and knowledge of HPV-related oropharyngeal cancer were not associated with years in practice, practice type or patient population served.

CONCLUSIONS

Increased awareness regarding HPV-related oropharyngeal cancers among primary care providers may increase HPV immunization rates, especially in males.

 

Log in to read full article.

Member Login